Intratympanic gentamicin in Ménière's disease: Results of therapy

American Journal of Otology

Volumn 18, Issue 1, 1997, Pages 52-57

  Murofushi, Toshihisa ^a,b   Halmagyi, G Michael ^a   Yavor, Robbie A ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Aminoglycoside; Gentamicin; Labyrinthectomy; M ni re's disease

Indexed keywords

GENTAMICIN;

ADULT; AGED; ARTICLE; CALORIC VESTIBULAR TEST; FEMALE; HEARING DISORDER; HUMAN; INNER EAR; MALE; MENIERE DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; PURE TONE AUDIOMETRY; TREATMENT OUTCOME; VERTIGO; CLINICAL ARTICLE; LABYRINTHECTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VESTIBULAR DISORDER;

ADULT; AGED; AUDIOMETRY, PURE-TONE; CALORIC TESTS; EAR, INNER; FEMALE; GENTAMICINS; HEARING DISORDERS; HUMANS; MALE; MENIERE'S DISEASE; MIDDLE AGED; TREATMENT OUTCOME; VERTIGO;

EID: 0030614608     PISSN: 01929763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Committee on Hearing and Equilibrium. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière's disease. Otolaryngol Head Neck Surg 1995;113:181-5.
2. Graham MD, Goldsmith MM. Labyrinthectomy. Indications and surgical technique. Otolaryngol Clin North Am 1994; 27:325-35.
3. Bergenius J, Ödkvist LM. Transtympanic aminoglycoside treatment in Ménière's disease. In: Baloh RW, Halmagyi GM, eds. Disorders of the vestibular system. New York: Oxford University Press, 1996:575-82.
4. Hellström S, Ödkvist L. Pharmacologic labyrinthectomy. Otolaryngol Clin North Am 1994;27:307-15.
5. Aran J-M. Current perspectives on inner ear toxicity. Otolaryngol Head Neck Surg 1995;112:133-44.
6. Halmagyi GM, Fattore CM, Curthoys IS, Wade S. Gentamicin vestibulotoxicity. Otolaryngol Head Neck Surg 1994;111:571-4.
7. Magnusson M, Padoan S. Delayed onset of ototoxic effects of gentamicin in treatment of Ménière's disease. Rationale for extremely low dose therapy. Acta Otolaryngol (Stockh) 1991;111: 671-6.
8. Beck C, Schmidt CL. Ten years of experience with intratympanally applied streptomycin (gentamicin) in the therapy of morbus Ménière. Arch Otorhinolaryngol 1978;221:149-52.
9. Curthoys IS, Halmagyi GM. Vestibular compensation: a review of the oculomotor, neural, and clinical consequences of unilateral vestibular loss. J Vestib Res 1995;5:67-107.
10. Nomura Y. Otological significance of the round window. Adv Otorhinolaryngol 1984;33:1-162.
11. Goycoolea MV. The round window membrane under normal and pathological conditions. Acta Otolaryngol (Stockh) 1992; 8493:43-55.
12. Hayashida T, Hiel H, Dulon D, Erre J-P, Guilhaume A, Aran J-M. Dynamic changes following combined treatment with gentamicin and ethacrynic acid with and without acoustic stimulation. Cellular uptake and functional correlates. Acta Otolaryngol (Stockh) 1989;108:404-13.
13. Tran Ba Huy P, Bernard P, Schacht J. Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs. J Clin Invest 1986;77:1492-500.
14. Kimura RS, Iverson NA, Southard RE. Selective lesions of the vestibular labyrinth. Ann Otol Rhinol Laryngol 1988;97:577-84.
15. Bagger-Sjöbäck D, Bergenius J, Lundberg A-M. Inner ear effects of topical gentamicin treatment in patients with Ménière's disease. Am J Otol 1990;6:406-10.
16. Pender DJ. Gentamicin tympanoclysis: effects on the vestibular secretory cells. Am J Otolaryngol 1985;6:358-67.
17. Yoshihara T, Kaname H, Ishii T, Igarashi M. Effect of gentamicin on vestibular dark cells and melanocytes: an ultrastructural and cytochemical study. ORL 1994;56:24-30.
18. Hutchin T, Cortopassi G. Proposed molecular and cellular mechanism for aminoglycoside ototoxicity. Antimicrob Agents Chemother 1994;38:2517-20.
19. Kroese ABA, Das A, Hudspeth AJ. Blockage of transduction channels of hair cells in bullfrog's sacculus by aminoglycoside antibiotics. Hear Res 1989;37:203-18.
20. Ödkvist LM, Bergenius J. Drop attacks in Ménière's disease. Acta Otolaryngol (Stockh) 1988;S455:82-5.
21. Tumarkin A. The otolithic catastrophe: a new syndrome. BMJ 1936;2:175-7.
22. Baloh RW, Jacobson K, Winder T. Drop attacks with Ménière's syndrome. Ann Neurol 1990;28:384-7.
23. Monsell EM, Brackmann DE, Linthicum FH Jr. Why do vestibular destructive procedures sometimes fail? Otolaryngol Head Neck Surg 1988;99:472-9.
24. Halmagyi GM. Vestibular insufficiency following unilateral vestibular deafferentation. Aust J Otolaryngol 1994;1:510-2.
25. Aw ST, Halmagyi GM, Curthoys IS, Todd MJ, Yavor RA. Unilateral vestibular deafferentation causes permanent impairment of the human vertical vestibulo-ocular reflex in the pitch plane. Exp Brain Res 1994;102:121-30.
26. Kimura RS. Distribution, structure, and function of dark cells in the vestibular labyrinth. Ann Otol Rhinol Laryngol 1969;78:542-61.
27. Nakai Y, Hilding D. Vestibular endolymph-producing epithelium. Acta Otolaryngol (Stockh) 1968;66:120-8.
28. Ödkvist LM. Middle ear ototoxic treatment for inner ear disease. Acta Otolaryngol (Stockh) 1988;S457:83-6.
29. Nedzelski JM, Chiong CM, Fradet G, Schessel DA, Bryce GE, Pfeiderer AG. Intratympanic gentamicin instillation as treatment of unilateral Ménière's disease: update of an ongoing study. Am J Otol 1993;14:278-82.